// App-Quantinova.ai

10032 : Estimated long-term outcomes in children newly diagnosed with standard risk acute lymphoblastic leukemia (ALL) based on similarly treated members of the childhood cancer survivor study (CCSS) cohort.

Researchers

Presenter

  • Stefan Essig

Principal Investigators

  • Qiaozhi Li

  • Yan Chen

  • Kevin C. Oeffinger

  • Leslie L. Robison

  • Yutaka Yasui

  • Paul C. Nathan

  • Johann Hitzler

  • Wendy M. Leisenring

  • Mark L. Greenberg

  • Charles A. Sklar

  • Melissa M. Hudson

  • Gregory T. Armstrong

  • Kevin R. Krull

  • Joseph Philip Neglia

Medical Centers

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • University of Minnesota, Minneapolis, MN

  • Institute of Social and Preventive Medicine, Bern, Switzerland

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • St. Jude Children's Research Hospital, Memphis, TN

  • Hospital for Sick Children, Toronto, ON, Canada

  • University of Alberta, Edmonton, AB, Canada

Locations

  • United States

  • Canada

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Mismatch repair deficiency

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved